Idenix Pharmaceuticals to Present at the Oppenheimer 23rd Annual Healthcare Conference
05 déc. 2012 16h05 HE
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., Dec. 5, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that Idenix management will present a corporate overview at the Oppenheimer 23rd Annual...
Idenix Pharmaceuticals to Present at the 2012 Deutsche Bank Access BioFEST Conference
26 nov. 2012 16h05 HE
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., Nov. 26, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that Idenix management will present in a fireside chat at the 2012 Deutsche Bank Access...
Idenix Pharmaceuticals Reports Clinical Data for HCV Drug Candidates - IDX719 and IDX184 - at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting
10 nov. 2012 09h05 HE
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., Nov. 10, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human...
Idenix Pharmaceuticals Reports Third Quarter and Nine Month 2012 Financial Results and HCV Program Update
01 nov. 2012 16h05 HE
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., Nov. 1, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human...
Idenix to Host Conference Call Discussing Third Quarter and Nine Month 2012 Financial Results and HCV Program Update
25 oct. 2012 16h05 HE
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., Oct. 25, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc., (Nasdaq:IDIX) announced today that it will report its financial results for the third quarter of 2012 on Thursday,...
Idenix Pharmaceuticals to Present at the UBS Global Life Sciences Conference
13 sept. 2012 16h05 HE
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., Sept. 13, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that Idenix management will present a corporate overview at the UBS Global Life Sciences...
Idenix Pharmaceuticals to Present at Three Upcoming Investor Conferences
29 août 2012 16h05 HE
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., Aug. 29, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), announced today that Idenix management will participate in a panel discussion at Citigroup's 7th Annual...
Idenix Provides Update on IDX19368 Development Program
27 août 2012 08h30 HE
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., Aug. 27, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human...
Idenix Provides Update on IDX184 Clinical Development Program
16 août 2012 08h00 HE
|
Idenix Pharmaceuticals
IDX184 has been placed on partial clinical hold by FDA
Management to host a conference call webcast today at 8:30 am ET
CAMBRIDGE, Mass., Aug. 16, 2012 (GLOBE NEWSWIRE) -- Idenix...
Idenix Pharmaceuticals to Present at the 2012 Wedbush PacGrow Lifesciences Management Access Conference
09 août 2012 08h30 HE
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., Aug. 9, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that Idenix management will present a corporate overview at the 2012 Wedbush PacGrow...